Home » Matthew Henn (Seres Therapeutics): ‘Microbiome research will have a large impact on human health’
Watch our interview with Matthew Henn, Executive Vice President and Chief Scientific Officer of Seres Therapeutics.
MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome.
Published by Clorofilla Srl.
© 2016-2023 Clorofilla SrlVia Podgora 12/A, 20122, Milan, Italy – VAT: 05299040963
© ALL RIGHTS RESERVED